SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 181.46-2.4%Feb 12 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mudcat who wrote (27037)12/28/1998 7:51:00 AM
From: Henry Niman  Read Replies (3) of 32384
 
The Aug 12, 1998 press release described the addition of Knight Aquisition Co:

BW0235 AUG 12,1998 14:19 PACIFIC 17:19 EASTERN

( BW)(LIGAND-PHARMACEUTICALS)(LGND) Ligand Completes Merger With Seragen; Seragen Stockholders Approve
Merger Today

Business Editors/Health Writers

SAN DIEGO--(BW HealthWire)--Aug. 12, 1998--Ligand (LYE-gand) Pharmaceuticals Incorporated (NASDAQ:LGND) announced today that its merger with
Seragen Inc. (OTCBB:SRGN) has been approved by a majority of Seragen stockholders.
Under the companies' definitive merger agreement, a wholly owned subsidiary of Ligand, Knight Acquisition Corp., merged with Seragen and Seragen became a
wholly owned subsidiary of Ligand
. More than 97 percent by voting power of Seragen capital stock present or represented at a special meeting held this morning
voted in favor of the merger. Those voting were a majority by total voting power of Seragen capital stock............
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext